Literature DB >> 4042426

Inappropriate responses to Mycobacterium leprae infections--C reactive protein in man and serum amyloid P in mice.

R A Thompson, K D Sukumaran, K Rajagopalan.   

Abstract

In a study of C-reactive protein (CRP) levels in the sera of 77 patients with leprosy, it was found that in the majority of newly diagnosed patients, the level was within the normal range for a healthy Malaysian population. Elevated levels did occur, but were usually found in patients with complications, and were more likely to occur in patients who had been receiving drug treatment for some time. This suggested that Mycobacterium leprae infection by itself does not stimulate CRP synthesis and could reflect a failure of synthesis by macrophages of interleukin-1, or related molecules. This was supported by the study of an analogous acute phase protein, serum amyloid P (SAP) in mice bearing M. leprae from human sources in their hind footpads. Such mice showed no significant difference in SAP levels from control mice.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4042426      PMCID: PMC1577318     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  12 in total

1.  Biochemical, immunological and genetic studies in leprosy. II. Profile of immunoglobulins, complement components and C-reactive protein in sera of leprosy patients and healthy controls.

Authors:  L M Srivastava; D P Agarwal; H W Goedde; R Rohde
Journal:  Tropenmed Parasitol       Date:  1975-06

2.  Epidemiology of cutaneous leishmaniasis in Kabul, Afghanistan.

Authors:  A Nadim; G S Rostami
Journal:  Bull World Health Organ       Date:  1974       Impact factor: 9.408

3.  Isolation and analysis of circulating immune complexes in leprosy.

Authors:  V D Ramanathan; O Parkash; G Ramu; D Parker; J Curtis; U Sengupta; J L Turk
Journal:  Clin Immunol Immunopathol       Date:  1984-09

Review 4.  Acute phase proteins with special reference to C-reactive protein and related proteins (pentaxins) and serum amyloid A protein.

Authors:  M B Pepys; M L Baltz
Journal:  Adv Immunol       Date:  1983       Impact factor: 3.543

5.  Human immunoregulatory molecules: interleukin 1, interleukin 2, and B-cell growth factor.

Authors:  L B Lachman; A L Maizel
Journal:  Contemp Top Mol Immunol       Date:  1983

6.  [The biology of the African leprosy patient. Apropos of 442 cases].

Authors:  J Languillon; J M Ndiaye; G Roux
Journal:  Acta Leprol       Date:  1981 Jan-Mar

7.  Evidence for an in vivo inflammatory role of interleukin 1 (IL 1).

Authors:  J J Oppenheim; J A Charon; T A Luger
Journal:  Transplant Proc       Date:  1982-09       Impact factor: 1.066

8.  C-reactive protein and apoB containing lipoproteins are associated with Mycobacterium leprae in lesions of human leprosy.

Authors:  M J Ridley; D S Ridley; F C De Beer; M B Pepys
Journal:  Clin Exp Immunol       Date:  1984-06       Impact factor: 4.330

9.  Serological study for presence of C-reactive protein, rheumatoid factor, anti streptolysin O in leprosy cases.

Authors:  V N Bhatia; S Balakrishnan; S Harikrishnan
Journal:  Lepr India       Date:  1983-01

10.  Interleukin 1 production by peripheral blood mononuclear cells from leprosy patients.

Authors:  S Watson; W Bullock; K Nelson; V Schauf; R Gelber; R Jacobson
Journal:  Infect Immun       Date:  1984-09       Impact factor: 3.441

View more
  2 in total

1.  Serum levels of C-reactive protein in patients with pulmonary tuberculosis and malignant tumors of the chest.

Authors:  P Maasilta; A A Kostiala
Journal:  Infection       Date:  1989 Jan-Feb       Impact factor: 3.553

2.  C-reactive protein in patients with lymphatic filariasis: increased expression on lymphocytes in chronic lymphatic obstruction.

Authors:  R B Lal; R R Dhawan; R M Ramzy; R M Farris; A A Gad
Journal:  J Clin Immunol       Date:  1991-01       Impact factor: 8.317

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.